The blood products company is still looking like a good buy. The post Morgan Stanley just upgraded their CSL share price ...

The CSL Ltd (ASX: CSL) share price has had a difficult run. At around $140.31, it is sitting much closer to its 52-week low of $133.35 than its high of $275.79. For one of the highest-quality names on ...

Experts reveal new ratings on Cleanaway Waste Management Ltd (ASX: CWY), New Hope Corporation Ltd (ASX: NHC), and CSL Ltd ...

Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. If you are wondering whether ...

The CSL Ltd (ASX: CSL) share price has almost doubled from its June low. Here’s what I think needs to happen for it to reach $200.

CSL shares (ASX: CSL) reclaimed the A$180 mark on Wednesday, closing at A$181.99 after a 1.85% gain that bulls will be ...

CSL Limited trades at a decade-low P/E, despite ongoing revenue and profit growth, presenting significant upside potential. CSL's vaccine business volatility and slow margin recovery, especially at ...

CSL (ASX:CSL) has put kidney and liver disease firmly in focus, committing an upfront US$355 million to partner with Alentis Therapeutics on lixudebart and agreeing to fund upcoming Phase 2 and 3 ...

Australian fund managers piled into the one-time blue-chip health giant last month, with the stock now the top position held by local equity fund managers.

CSL Limited has provided an updated notification to the ASX on the progress of its on-market share buy-back program for ordinary fully paid shares. The update, dated 4 March 2026, reports that a total ...